Health ❯ Healthcare ❯ Biotechnology

Pharmaceuticals

Cystic Fibrosis Treatments Argenx SE AI in Healthcare Insmed Incorporated Cancer Treatment Antidotes Autoimmune Therapies Drug Development Drug Approval Process Chronic Obstructive Pulmonary Disease Health Startups RNA Interference Rare Diseases Regeneron Regulatory Affairs ALS Treatments Biopharmaceutical Companies

Investor Class Actions Target Atara Over FDA Setbacks to EBVALLO

Filings focus on alleged nondisclosure of manufacturing lapses plus ALLELE trial flaws that undercut approval prospects.

Artisan Mid Cap Fund Tops Benchmark in Q3, Shifts Toward Defense and Industrials

PGIM Jennison’s Q2 Letter Details Health-Care Slide, Portfolio Shifts and Company Catalysts

Cytokinetics Hit With Securities Class Action Over Aficamten Timeline Disclosures

Biotech Veterans Launch Corsera Health to Develop a Once‑Yearly RNAi Heart Prevention Shot